Investigation of the effect of interleukin-1 receptor antagonist on markers of inflammation in non-ST elevation acute coronary syndromes.
Phase of Trial: Phase II
Latest Information Update: 30 Jan 2014
At a glance
- Drugs Anakinra (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Acronyms MRC-ILA-HEART
- 30 Jan 2014 United Kingdom Clinical Research Network reports accrual to date is 97%
- 19 Nov 2013 Results presented at the 86th Annual Scientific Sessions of the American Heart Association.
- 31 May 2012 Additional trial locations added as reported by United Kingdom Clinical Research Network.